Alpha 2.0
Login Register
» Authors » A Bellucci

A Bellucci

Explore the profile of A Bellucci including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 179
Followers 0
Related Specialties
Pharmacology
General Medicine
General Surgery
Top 10 Co-Authors
F Casamenti
C Scali
M G Giovannini
G Pepeu
B M Wilkes
L Pacifici
M Girolami
C Prosperi
R Polini
D M Trucchi
Published In
J Cardiovasc Pharmacol
Int J Immunopathol Pharmacol
G Chir
Neuroscience
Nature
Affiliations
Soon will be listed here.
Recent Articles
1.
Novel concepts and nanostructured materials for thermionic-based solar and thermal energy converters
Bellucci A, Girolami M, Mastellone M, Orlando S, Polini R, Santagata A, et al.
Nanotechnology . 2020 Sep; 32(2):024002. PMID: 32957094
Thermal and concentrated solar solid-state converters are devices with no moving parts, corresponding to long lifetimes, limited necessity of maintenance, and scalability. Among the solid-state converters, the thermionic-based devices are...
2.
North Atlantic climate far more predictable than models imply
Smith D, Scaife A, Eade R, Athanasiadis P, Bellucci A, Bethke I, et al.
Nature . 2020 Jul; 583(7818):796-800. PMID: 32728237
Quantifying signals and uncertainties in climate models is essential for the detection, attribution, prediction and projection of climate change. Although inter-model agreement is high for large-scale temperature signals, dynamical changes...
3.
Thermoelectric Analysis of ZnSb Thin Films Prepared by ns-Pulsed Laser Deposition
Bellucci A, Mastellone M, Mezzi A, Kaciulis S, Polini R, Medici L, et al.
J Nanosci Nanotechnol . 2018 Apr; 17(3):1564-570. PMID: 29693353
Zinc antimonide (ZnSb) is a promising thermoelectric material for the temperature range 300– 600 K. ZnSb thin films were prepared by nanosecond Pulsed Laser Deposition (PLD) to evaluate the performance...
4.
Risk factors and disease prevalence in 3331 personal check-ups performed in preventive medicine between 2006 and 2011. cross-sectional and follow-up study
Keipes M, Bellucci A, Hansen E
Bull Soc Sci Med Grand Duche Luxemb . 2013 Feb; (2):25-35. PMID: 23362564
Introduction: The present data results from a retrospective analysis of 3331 check-ups made in the preventive medicine department of the "ZithaKlinik", named "ZithaGesondheetsZentrum". These check-ups are done for the employee's...
5.
Differential activation of mitogen-activated protein kinase signalling pathways in the hippocampus of CRND8 transgenic mouse, a model of Alzheimer's disease
Giovannini M, Cerbai F, Bellucci A, Melani C, Grossi C, Bartolozzi C, et al.
Neuroscience . 2008 Apr; 153(3):618-33. PMID: 18406062
Transgenic Centre for Research in Neurodegenerative Diseases 8 (TgCRND8) mice expressing a double mutant form of human amyloid precursor protein represent a good model of Alzheimer's disease, and can be...
6.
Charon's size and an upper limit on its atmosphere from a stellar occultation
Sicardy B, Bellucci A, Gendron E, Lacombe F, Lacour S, Lecacheux J, et al.
Nature . 2006 Jan; 439(7072):52-4. PMID: 16397493
Pluto and its satellite, Charon (discovered in 1978; ref. 1), appear to form a double planet, rather than a hierarchical planet/satellite couple. Charon is about half Pluto's size and about...
7.
Comparison between flurbiprofen and its nitric oxide-releasing derivatives HCT-1026 and NCX-2216 on Abeta(1-42)-induced brain inflammation and neuronal damage in the rat
Prosperi C, Scali C, Barba M, Bellucci A, Giovannini M, Pepeu G, et al.
Int J Immunopathol Pharmacol . 2004 Oct; 17(3):317-30. PMID: 15461866
Brain inflammation is an underlying factor in the pathogenesis of Alzheimers disease (AD). We investigated, in vivo, whether differences exist in the anti-inflammatory and neuroprotective actions of flurbiprofen and its...
8.
Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors
Giovannini M, Scali C, Prosperi C, Bellucci A, Pepeu G, Casamenti F
Int J Immunopathol Pharmacol . 2003 Oct; 16(2 Suppl):31-40. PMID: 14552702
Epidemiological studies indicate that long-term treatment with non-steroidal anti-inflammatory drugs reduces the risk of Alzheimer Disease and may delay its onset or slow its progression. Neuroinflammation occurs in vulnerable regions...
9.
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo
Scali C, Giovannini M, Prosperi C, Bellucci A, Pepeu G, Casamenti F
Neuroscience . 2003 Mar; 117(4):909-19. PMID: 12654342
Brain inflammatory processes underlie the pathogenesis of Alzheimer's disease, and non-steroidal anti-inflammatory drugs have a protective effect in the disease. The aim of this work was to study in vivo...
10.
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats
Scali C, Casamenti F, Bellucci A, Costagli C, Schmidt B, Pepeu G
J Neural Transm (Vienna) . 2002 Jul; 109(7-8):1067-80. PMID: 12111444
The changes in extracellular acetylcholine levels were investigated by microdialysis in the cortex and hippocampus of aging rats after administration of metrifonate (80 mg/kg), rivastigmine (0.75 mg/kg), donepezil (1.5 mg/kg)...